SCHEMBL23964276

SCHEMBL23964276

CC(C)NC(=O)C(C)CC(C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
FOLH1 Q04609 2/20 0.33
NAALAD2 Q9Y3Q0 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
CA9 Q16790 1/20 0.33
TSHR P16473 1/20 0.33
DPP4 P27487 2/20 0.32
FAAH O00519 1/20 0.32
MAPK1 P28482 1/20 0.32
FAP Q12884 1/20 0.32
DPP8 Q6V1X1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10213728 0.81 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ALMNAFOLH1
SCHEMBL23178017 0.79 MMP1 (0.37) MMP1MMP2MMP9MMP8
SCHEMBL12890781 0.79 ALDH1A1 (0.36) ALDH1A1MEN1KMT2ALMNAFOLH1
SCHEMBL22343466 0.77 MEN1 (0.35) ALDH1A1MEN1KMT2ALMNAFOLH1
SCHEMBL18513092 0.76 TSHR (0.35) KMT2ALMNAFOLH1NAALAD2MMP1
SCHEMBL18232002 0.76 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ALMNAFOLH1
SCHEMBL15698018 0.74 USP2 (0.40) ALDH1A1MEN1KMT2ALMNACA12
SCHEMBL24786948 0.74 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ALMNAFOLH1
SCHEMBL15299596 0.74 BACE1 (0.43) BACE1
SCHEMBL10031629 0.73 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AFOLH1NAALAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330798-A1 TREATMENT OF INFECTIONS ASCENDIS PHARMA A/S (DK) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330798-A1 TREATMENT OF INFECTIONS H1-10, PM20D2, ELANE ALDH1A1 1667/4885MEN1 1654/4885KMT2A 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.